14 Einträge gefunden

1. Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease.

   1. Wolff, Daniel
   2. Schleuning, Michael
   3. von Harsdorf, Stephanie
   4. Bacher, Ulrike
   5. Gerbitz, Armin
   6. Stadler, Michael
   7. Ayuketang Ayuk, Francis

   2011 - Forschungsinformationssystem des UKE
2. Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation.

   1. Kröger, Nicolaus
   2. Shimoni, Avichai
   3. Schilling, Georgia
   4. Schwerdtfeger, Rainer
   5. Bornhäuser, Martin
   6. Nagler, Arnon
   7. Zander, Axel R.

   2010 - Forschungsinformationssystem des UKE
3. Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV.

   1. Saussele, Susanne
   2. Lauseker, Michael
   3. Gratwohl, Alois
   4. Beelen, Dietrich W
   5. Bunjes, Donald
   6. Schwerdtfeger, Rainer
   7. Kolb, Hans-Jochem

   2009 - Forschungsinformationssystem des UKE
4. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.

   1. Finke, Jürgen
   2. Bethge, Wolfgang A
   3. Schmoor, Claudia
   4. Ottinger, Hellmut D
   5. Stelljes, Matthias
   6. Zander, Axel R.
   7. Volin, Liisa

   2009 - Forschungsinformationssystem des UKE
5. Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

   1. Kröger, Nicolaus
   2. Holler, Ernst
   3. Kobbe, Guido
   4. Bornhäuser, Martin
   5. Schwerdtfeger, Rainer
   6. Baurmann, Herrad
   7. Nagler, Arnon

   2009 - Forschungsinformationssystem des UKE
6. Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.

   1. Ayuketang Ayuk, Francis
   2. Perez-Simon, José A
   3. Shimoni, Avichai
   4. Sureda, Anna
   5. Zabelina, Tatjana
   6. Schwerdtfeger, Rainer
   7. Martino, Rodrigo

   2008 - Forschungsinformationssystem des UKE - frei zugänglich
7. Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS).

   1. Platzbecker, Uwe
   2. Bornhäuser, Martin
   3. Germing, Ulrich
   4. Stumpf, Julian
   5. Scott, Bart L
   6. Kröger, Nicolaus
   7. Schwerdtfeger, Rainer

   2008 - Forschungsinformationssystem des UKE
8. Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis.

   1. Kröger, Nicolaus
   2. Thiele, Jürgen
   3. Zander, Axel R.
   4. Schwerdtfeger, Rainer
   5. Kobbe, Giudo
   6. Bornhäuser, Martin
   7. Bethge, Wolfgang

   2007 - Forschungsinformationssystem des UKE
9. Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study.

   1. Bornhäuser, Martin
   2. Kröger, Nicolaus
   3. Schwerdtfeger, Rainer
   4. Schafer-Eckart, Karin
   5. Sayer, Herbert G
   6. Scheid, Christoph
   7. Stelljes, Mattias

   2006 - Forschungsinformationssystem des UKE
10. Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma.

    1. Kröger, Nicolaus
    2. Shaw, Bronwen
    3. Iacobelli, Simona
    4. Zabelina, Tatjana
    5. Peggs, Karl
    6. Shimoni, Avichai
    7. Nagler, Arnon

    2005 - Forschungsinformationssystem des UKE
11. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.

    1. Kiehl, Michael G
    2. Kraut, Ludwig
    3. Schwerdtfeger, Rainer
    4. Hertenstein, Bernd
    5. Remberger, Mats
    6. Kröger, Nicolaus
    7. Stelljes, Mathias

    2004 - Forschungsinformationssystem des UKE
12. Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.

    1. Kröger, Nicolaus-Martin
    2. Perez-Simon, Jose A
    3. Myint, Han
    4. Klingemann, Hans
    5. Shimoni, Avichai
    6. Nagler, Arnon
    7. Martino, Rodrigo

    2004 - Forschungsinformationssystem des UKE
13. Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma.

    1. Kröger, Nicolaus-Martin
    2. Schwerdtfeger, Rainer
    3. Kiehl, Michael
    4. Sayer, Herbert Gottfried
    5. Renges, Helmut-Hans
    6. Zabelina, Tatjana
    7. Fehse, Boris

    2002 - Forschungsinformationssystem des UKE
14. Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality.

    1. Kröger, Nicolaus
    2. Sayer, Herbert Gottfried
    3. Schwerdtfeger, Rainer
    4. Kiehl, Michael
    5. Nagler, Arnon
    6. Renges, Helmut
    7. Zabelina, Tatjana

    2002 - Forschungsinformationssystem des UKE